New Millennium Group’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $159 | Sell |
16
-18
| -53% | -$179 | ﹤0.01% | 394 |
|
|
2025
Q1 | $323 | Sell |
34
-25
| -42% | -$238 | ﹤0.01% | 436 |
|
|
2024
Q4 | $814 | Hold |
59
| – | – | ﹤0.01% | 472 |
|
|
2024
Q3 | $897 | Hold |
59
| – | – | ﹤0.01% | 338 |
|
|
2024
Q2 | $281 | Buy |
+59
| New | +$281 | ﹤0.01% | 387 |
|
|
2024
Q1 | – | Sell |
-59
| Closed | -$289 | – | 116 |
|
|
2023
Q4 | $289 | Hold |
59
| – | – | ﹤0.01% | 406 |
|
|
2023
Q3 | $202 | Hold |
59
| – | – | ﹤0.01% | 383 |
|
|
2023
Q2 | $282 | Hold |
59
| – | – | ﹤0.01% | 385 |
|
|
2023
Q1 | $249 | Hold |
59
| – | – | ﹤0.01% | 405 |
|
|
2022
Q4 | $228 | Hold |
59
| – | – | ﹤0.01% | 443 |
|
|
2022
Q3 | $0 | Sell |
59
-10
| -14% | – | ﹤0.01% | 370 |
|
|
2022
Q2 | $0 | Buy |
+69
| New | – | ﹤0.01% | 360 |
|